Intrivo is a digital health company whose mission is to help people live happier, healthier and longer lives by providing them with intuitive tools and comprehensive health information to steward them across their entire health journey. In the midst of the current COVID-19 pandemic, we’ve been focused on helping companies reopen the economy, and individuals rediscover and reconnect through the use of rapid tests. We are the exclusive U.S. commercialization partner to Access Bio, an innovative diagnostics company that has received EUA approval for their CareStart™ COVID-19 Antigen test (as well as the CareStart PCR and Antibody tests). This CareStart™ antigen test gives results in 10 minutes with no additional equipment needed.
Intrivo Diagnostics, Inc.
Digital Healthcare Diagnostic Testing and Related Products and Services
Region 14 ESC
3 year term, December 13, 2021 to December 31, 2024
*Option to renew for two (2) additional one (1) year periods.
Request for Proposal:
RFP for Digital Healthcare Diagnostic Testing and Related Products and Services
Awarded Vendor Response:
Intrivo's Response to RFP
Bid Tab & Request for RFP List
Region 14 Award Letter
USA Today Ad 1
USA Today Ad 2
NCPA Website Ad